← SynDRA
PRT-062607
SynDRA canonical compound SYN0062932 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | FGR | MAP3K9 | SYK |
| Mechanism of action | SYK inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- (REL)-P505-15
- (REL)-PRT062607
- BIIB-057
- BIIB057
- P 505-15
- P505-15
- PRT-2607
- PRT062607
- P-14276
- P-505-15
- Syk tyrosine kinase inhibitors (oral, cancers/inflammatory diseases/thrombosis), Portola
- PRT 062607
- CHEMBL2177736
- K9C42672RH
- 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide
- 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide
- 4-((3-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide
- 4-(3-(2H-1,2,3-Triazol-2-yl)phenylamino)-2-((1R,2S)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
- 5-Pyrimidinecarboxamide, 2-(((1R,2S)-2-aminocyclohexyl)amino)-4-((3-(2H-1,2,3-triazol-2-yl)phenyl)amino)-
- 2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-{[3-(2h-1,2,3-Triazol-2-Yl)phenyl]amino}pyrimidine-5-Carboxamide
- SCHEMBL899872
- UNII-K9C42672RH
- GTPL8070
- AMY9038
- EX-A1592
- BDBM50400047
- NSC776786
- ZINC95572830
- CS-3535
- NSC-776786
- NCGC00351606-09
- HY-15322
- E98978
- BRD-K53734668-003-04-6
- Q27088231
- P505-15, PRT062607,PRT-2607, BIIB-057
- 4-(3-(2H-1,2,3-TRIAZO-2-YL)PHENYLAMINO)-2-((1R,2S)-2-AMINOCYCLOHEXYLAMINO) PYRIMIDINE-5-CARBOXAMIDE
- 5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, rel-
- PRT062607 Hydrochloride
Look up PRT-062607 in the interactive SynDRA portal →